Stay updated on Cabozantinib in HR+ Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the Cabozantinib in HR+ Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Cabozantinib in HR+ Breast Cancer Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    No significant changes detected on the page; the study title, overview, eligibility criteria, and locations appear unchanged.
    Difference
    0.4%
    Check dated 2025-11-03T01:15:02.000Z thumbnail image
  2. Check
    14 days ago
    No Change Detected
  3. Check
    36 days ago
    Change Detected
    Summary
    Overall, the page updates to announce a system status notice and a new software version (v3.2.0), removing the previous v3.1.0 reference.
    Difference
    4%
    Check dated 2025-10-05T10:21:42.000Z thumbnail image
  4. Check
    43 days ago
    Change Detected
    Summary
    Version updated from v3.0.2 to v3.1.0; no other content changes detected.
    Difference
    0.1%
    Check dated 2025-09-28T03:21:37.000Z thumbnail image
  5. Check
    57 days ago
    Change Detected
    Summary
    Version bumped from v3.0.1 to v3.0.2; the 'Back to Top' link was removed as part of a minor UI cleanup.
    Difference
    0.2%
    Check dated 2025-09-13T17:43:26.000Z thumbnail image
  6. Check
    64 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content or important information.
    Difference
    0.2%
    Check dated 2025-09-06T15:26:45.000Z thumbnail image
  7. Check
    72 days ago
    Change Detected
    Summary
    The web page has undergone significant updates, including the addition of new facility names and locations, as well as detailed information on various hormonal compounds and pathological conditions. Notably, the revision number has been updated to v3.0.0.
    Difference
    4%
    Check dated 2025-08-30T12:13:16.000Z thumbnail image

Stay in the know with updates to Cabozantinib in HR+ Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Cabozantinib in HR+ Breast Cancer Clinical Trial page.